Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback